Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

NCT02468375 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
434
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center